"10.1371_journal.pone.0134353","plos one","2015-09-21T00:00:00Z","Gunnstein Norheim; Holly Sanders; Jardar W Mellesdal; Idunn Sundf√∏r; Hannah Chan; Carina Brehony; Caroline Vipond; Chris Dold; Rory Care; Muhammad Saleem; Martin C J Maiden; Jeremy P Derrick; Ian Feavers; Andrew J Pollard","Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom; Norwegian Institute of Public Health, Oslo, Norway; National Institute of Biological Standards and Control, Potters Bar, United Kingdom; Department of Zoology, University of Oxford, Oxford, United Kingdom; University of Manchester, Manchester, United Kingdom","Conceived and designed the experiments: GN HS IF JD AJP JWM IS CB. Performed the experiments: GN HS HC CV JWM IS CD CV. Analyzed the data: GN HS CD AJP MCJM IS JWM. Contributed reagents/materials/analysis tools: GN MS IF HC IS JWM RC. Wrote the paper: GN HS IF AJP CB. Genomic analyses: CB. Critically revised the manuscript: GN HS JWM IS HC CB CV CD RC MS MCJM JPD IF AJP.","AP, JP and MM are named inventors on a patent application concerning a PorA FetA vaccine but this application is no longer being pursued. AJP has led clinical trials of meningococcal vaccines on behalf of Oxford University sponsored by Novartis and Pfizer but does not receive any personal payments or travel funds from vaccine manufacturers. The Wellcome Trust has been involved in the decision to publish this work and critical review of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.","2015","09","Gunnstein Norheim","GN",14,TRUE,8,7,7,5,TRUE,TRUE,FALSE,0,NA,FALSE
